Minimally Invasive Surgery of the Gastro-esophageal Junction (MISGEJ)
This study will assess short and long term outcomes of individuals undergoing minimally invasive surgery of the gastro-esophageal junction (MISGEJ). Patients will respond to questionnaires on an annual basis evaluating quality of life and functionality following MISGEJ. Hospital charts will also be reviewed on an annual basis to assess patient health outcomes.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Functional Assessment Following Minimally Invasive Surgery of the Gastro-Esophageal Junction|
- MISGEJ symptoms (subjective) [ Time Frame: 8 years ] [ Designated as safety issue: No ]MISGEJ symptom questionnaire evaluated on an annual basis
- Achalasia Disease Severity (subjective) [ Time Frame: 8 years ] [ Designated as safety issue: No ]Achalasia Disease Severity questionnaire evaluated on an annual basis.
- Diagnostic imaging [ Time Frame: 8 years ] [ Designated as safety issue: No ]Patient x-rays, upper GI tests, Endoscopy, and/or CT scans will be assessed on an annual basis to objectively measure functionality and health status.
|Study Start Date:||November 2007|
|Estimated Primary Completion Date:||May 2015 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01799967
|Contact: Andrew JE Seely, MD, PhD||613-737-8899 ext email@example.com|
|Ottawa Hospital Research Institute||Recruiting|
|Ottawa, Ontario, Canada, K1H8L6|
|Sub-Investigator: Donna E Maziak, MD, MSc|
|Sub-Investigator: Sebastien Gilbert, MD|
|Sub-Investigator: Sudhir Sundaresan, MD|
|Sub-Investigator: Shamji Farid, MD|
|Sub-Investigator: Patrick James Villeneuve, MD, PhD|
|Principal Investigator: Andrew JE Seely, MD, PhD|
|Principal Investigator:||Andrew JE Seely, MD, PhD||Ottawa Hospital Research Institute|